Vivek Patil, MD in Baltimore: A Surgical Oncologist in the Johns Hopkins System

Vivek Patil is a surgical oncologist at Johns Hopkins Hospital who specializes in treating cancers of the breast, pancreas, bile duct, and liver. Unlike general surgeons or cancer specialists in private practice, Patil operates within an academic medical center where surgical oncology patients have access to clinical trials, tumor boards, and integrated medical and radiation oncology under one system. For Baltimore residents with a new cancer diagnosis, especially solid tumors requiring surgical evaluation, his location inside Johns Hopkins positions him within the region's most research-active cancer program.

What surgical oncology actually is

Surgical oncology differs from general surgery because it focuses exclusively on the surgical removal and staging of cancers. A general surgeon may handle appendicitis, gallbladders, and hernias; a surgical oncologist performs resections for malignancies, evaluates whether surgery is safe and beneficial, and works as part of a multidisciplinary team that includes medical oncologists and radiation specialists. Patil's practice at Johns Hopkins, which sits within the Johns Hopkins Hospital campus in East Baltimore, means patients are in a 1,000-bed academic center that sees high volumes of cancer cases daily. This scale matters for rare cancers or complex cases because surgeons manage more patients with similar conditions and stay current with evolving techniques.

Services and typical wait times

Patil evaluates patients for surgical treatment of breast cancer (lumpectomy, mastectomy, sentinel lymph node biopsy), pancreatic cancer, cholangiocarcinoma (bile duct cancer), and hepatocellular carcinoma. As a Johns Hopkins surgeon, he also leads tumor board discussions, meaning his recommendations are formed collaboratively with radiologists, pathologists, and other oncologists before surgery is scheduled. Initial consultations typically take 4 to 8 weeks to schedule; patients referred from within the Johns Hopkins system may access an earlier slot. No private pricing applies because cancer surgery is almost always covered by insurance (the cost is negotiated between Johns Hopkins and insurance plans); out-of-pocket responsibility depends entirely on the patient's plan and deductible. Johns Hopkins publishes its standard charges for surgical procedures but negotiated rates vary widely by insurer.

How Patil compares to other Baltimore surgical oncologists

Baltimore has surgical oncology capacity at Johns Hopkins, the University of Maryland Medical Center, and Mercy Medical Center, though Johns Hopkins maintains the highest surgical cancer volume and the only NCI-designated cancer center within the city proper. Surgical oncologists at the University of Maryland operate in a public, academic setting with high-acuity patient loads but smaller institutional resources than Johns Hopkins. Mercy Medical Center offers surgical oncology but primarily serves referrals from throughout the state rather than focusing on cancer surgery as a specialty. For a patient with a rare pancreatic cancer or complex liver tumor, Patil's setting at Johns Hopkins and its tumor board infrastructure increases the likelihood of access to multiple treatment perspectives before surgery occurs. For a straightforward breast cancer case, any of these three hospitals can provide capable surgical oncology care; the difference lies in research trial availability and the depth of subspecialized supporting services.

Who suits this surgeon and who does not

Patil's practice is appropriate for any patient in Baltimore with newly diagnosed or recurrent breast, pancreatic, bile duct, or liver cancer who is medically stable enough for surgery. Patients without insurance or with plans that do not include Johns Hopkins in-network coverage will face significantly higher out-of-pocket costs because Johns Hopkins charges higher rates to out-of-network insurers; in such cases, the University of Maryland Medical Center may offer more accessible pricing. Patients seeking a private practice experience, faster appointment access, or surgical care without academic medical center routines should consider Baltimore-area surgical oncologists in smaller group practices (though few exist exclusively in oncology). Patients with stage 4 metastatic disease or very poor performance status may be evaluated for comfort care rather than surgery, in which case the conversation shifts to medical oncology or palliative care specialists.

What an initial appointment involves

New patients bring all available pathology reports, imaging (CT, MRI, or ultrasound), and surgical history. Patil reviews the tumor stage, location, and patient health status, then discusses whether resection is technically feasible and likely to improve survival or quality of life. If surgery is recommended, he explains the specific procedure, risks, recovery timeline, and next steps with medical oncology if chemotherapy or radiation is indicated. The visit typically lasts 45 to 60 minutes. Patients should expect to discuss whether they wish to enroll in any available clinical trials; Johns Hopkins enrolls eligible cancer patients in trials regularly, and this option is presented directly during the consultation.

Hours, location, and logistics

Vivek Patil holds clinic at Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21287. Clinic hours run Monday through Friday, generally 8 a.m. to 4 p.m., but specific availability varies; patients should confirm hours by calling 410-955-2833. Johns Hopkins Hospital parking includes a main garage on the north side of the campus; parking rates are $3 per 15 minutes with a $24 daily cap for visitors (verification recommended, as rates are updated periodically). The hospital has public transportation access via the MARC Penn Line (Penn Station stop) and multiple bus routes. New patients should arrive 20 minutes early to complete registration and insurance verification.

Patil's presence in Baltimore's only NCI-designated cancer center gives local patients rapid access to second opinions, tumor board review, and the full span of cancer treatments on one campus. For Baltimore residents facing pancreatic or hepatic malignancy, this advantage is substantial.